• Home
  • Archive by category "criuclbv"

Meikles Limited (MEIK.zw) HY2009 Interim Report

first_imgMeikles Limited (MEIK.zw) listed on the Zimbabwe Stock Exchange under the Industrial holding sector has released it’s 2009 interim results for the half year.For more information about Meikles Limited (MEIK.zw) reports, abridged reports, interim earnings results and earnings presentations, visit the Meikles Limited (MEIK.zw) company page on AfricanFinancials.Document: Meikles Limited (MEIK.zw)  2009 interim results for the half year.Company ProfileMeikles Limited is an established 100-year old company in Zimbabwe primarily invested in the agriculture, hotels and retail sector. The company operates six business segments; hospitality, retail stores which include department stores, supermarkets and wholesalers, and agricultural, financial services and security. Its well-known brands include the Meikles Hotel, Victoria Falls Hotel, TM Supermarkets, Meikles Stores and Tanganda Tea which produces, packs and distributes Zimbabwe’s famous tea brand aswell as Tinga Mira, a bottled spring water brand. Tanganda Tea Company also owns estates that produce avocados and macadamia nuts. Meikles Limited has department stores in three major cities in Zimbabwe which includes Barbours department store in Harare; and has a national footprint with 50 retail stores in towns and cities throughout Zimbabwe. Meikles Limited recently expanded into the mining and guarding sector and owns Meikles Centar Mining and Meikles Guard Services (Private) Limited in Zimbabwe. Meikles Financial Services offers mobile financial solutions and bill payment services to the retail and commercial sector in Zimbabwe; under the brand name My Cash. Meikles Limited is listed on the Zimbabwe Stock Exchangelast_img read more

BK Group Plc (BOK.ke) 2010 Prospectus

first_imgBK Group Plc (BKG.ke) listed on the Nairobi Securities Exchange under the Banking sector has released it’s 2010 prospectus For more information about BK Group Plc (BKG.ke) reports, abridged reports, interim earnings results and earnings presentations, visit the BK Group Plc (BKG.ke) company page on AfricanFinancials.Document: BK Group Plc (BKG.ke)  2010 prospectus Company ProfileBK Group Plc formerly (Bank of Kigali Limited) is Rwanda’s largest commercial bank by assets and licensed by the country’s banking regulator, National Bank of Rwanda. It offers a full spectrum of products and services for retail banking, corporate banking and central treasury. Bank of Kigali SA commenced operations in 1967; initially as a joint venture between the government of Rwanda and Belgolaise, with each owning 50% of the ordinary share capital. In 2007, the government of Rwanda acquired the Belgolaise shareholding which increased its direct and indirect shareholding in the Bank of Kigali to 100% of the entire Issued Shares. The Bank changed its name to Bank of Kigali Limited in 2011 under a new law relating to companies. Bank of Kigali Limited now has 79 branches located in the main towns and cities of Rwanda with its head office in the capital city, Kigali. BK Group Plc has a primary listing on the Rwanda Stock Exchange and a secondary listing on the Nairobi Securities Exchangelast_img read more

Ikeja Hotel Plc (IKEJAH.ng) 2015 Annual Report

first_imgIkeja Hotel Plc (IKEJAH.ng) listed on the Nigerian Stock Exchange under the Tourism sector has released it’s 2015 annual report.For more information about Ikeja Hotel Plc (IKEJAH.ng) reports, abridged reports, interim earnings results and earnings presentations, visit the Ikeja Hotel Plc (IKEJAH.ng) company page on AfricanFinancials.Document: Ikeja Hotel Plc (IKEJAH.ng)  2015 annual report.Company ProfileIkeja Hotel Plc is a hotel development and management company with direct or indirect ownership of Sheraton Lagos Hotel, Sheraton Abuja Hotel and Federal Palace Hotels & Casino. The company targets the leisure, business and convention markets in Opebi, Ikeja and Lagos. Sheraton Lagos Hotel has 340 guest rooms and an impressive array of conferencing and recreational facilities, making it one of the largest hotels in Nigeria. Sheraton Abuja Hotel has 575 rooms and conference, restaurants and recreational facilities. Sun International’s Federal Palace Hotel & Casino is a luxury 5-star hotel conveniently located in the heart of Victoria Island’s commercial district and boasts luxury accommodation, a casino, conference facilities and an array of restaurants, bars and recreational facilities. Established in 1972 and formerly known as Properties Development Limited, the company changed its name to Ikeja Hotel Limited in 1980. The company’s head office is in Lagos, Nigeria. Ikeja Hotel Plc is listed on the Nigerian Stock Exchangelast_img read more

Southern Cross Tourist Company Limited (SCT.mu) Q12019 Interim Report

first_imgSouthern Cross Tourist Company Limited (SCT.mu) listed on the Stock Exchange of Mauritius under the Tourism sector has released it’s 2019 interim results for the first quarter.For more information about Southern Cross Tourist Company Limited (SCT.mu) reports, abridged reports, interim earnings results and earnings presentations, visit the Southern Cross Tourist Company Limited (SCT.mu) company page on AfricanFinancials.Document: Southern Cross Tourist Company Limited (SCT.mu)  2019 interim results for the first quarter.Company ProfileSouthern Cross Tourist Company Limited is a Mauritian company that has activities in the tourism and leisure sector where the company owns and operates hotels in Mauritius. The company manages hotels such as the Preskil Beach Resort at Pointe Jerome, Mahebourg, Astroea Beach at Pointe D’Esny, Mahébourg, and Solana Beach at Belle Mare, Mauritius. Southern Cross Tourist Company Limited is headquartered in Curepipe, Mauritius, and operates as a subsidiary of The Union Sugar Estates Co. Limited. Southern Cross Tourist Company Limited is listed on the Stock Exchange of Mauritius.last_img read more

“That’s one small step for a man, one giant leap for…

first_img July 23, 2018 at 5:37 pm On this day in history: July 20th, 1969Armstrong walks on the moonAt 10:56 p.m. EDT, American astronaut Neil Armstrong, 240,000 miles from Earth, speaks these words to more than a billion people listening at home: “That’s one small step for man, one giant leap for mankind.” Stepping off the lunar landing module Eagle, Armstrong became the first human to walk on the surface of the moon.The American effort to send astronauts to the moon has its origins in a famous appeal President John F. Kennedy made to a special joint session of Congress on May 25, 1961: “I believe this nation should commit itself to achieve the goal, before this decade is out, of landing a man on the moon and returning him safely to Earth.” At the time, the United States was still trailing the Soviet Union in space developments, and Cold War-era America welcomed Kennedy’s bold proposal.In 1966, after five years of work by an international team of scientists and engineers, the National Aeronautics and Space Administration (NASA) conducted the first unmanned Apollo mission, testing the structural integrity of the proposed launch vehicle and spacecraft combination. Then, on January 27, 1967, tragedy struck at Kennedy Space Center in Cape Canaveral, Florida, when a fire broke out during a manned launch-pad test of the Apollo spacecraft and Saturn rocket. Three astronauts were killed in the fire.Despite the setback, NASA and its thousands of employees forged ahead, and in October 1968, Apollo 7, the first manned Apollo mission, orbited Earth and successfully tested many of the sophisticated systems needed to conduct a moon journey and landing. In December of the same year, Apollo 8 took three astronauts to the dark side of the moon and back, and in March 1969 Apollo 9tested the lunar module for the first time while in Earth orbit. Then in May, the three astronauts of Apollo 10 took the first complete Apollo spacecraft around the moon in a dry run for the scheduled July landing mission.At 9:32 a.m. on July 16, with the world watching, Apollo 11 took off from Kennedy Space Center with astronauts Neil Armstrong, Edwin Aldrin Jr., and Michael Collins aboard. Armstrong, a 38-year-old civilian research pilot, was the commander of the mission. After traveling 240,000 miles in 76 hours, Apollo 11entered into a lunar orbit on July 19. The next day, at 1:46 p.m., the lunar module Eagle, manned by Armstrong and Aldrin, separated from the command module, where Collins remained. Two hours later, the Eagle began its descent to the lunar surface, and at 4:18 p.m. the craft touched down on the southwestern edge of the Sea of Tranquility. Armstrong immediately radioed to Mission Control in Houston, Texas, a famous message: “The Eagle has landed.”At 10:39 p.m., five hours ahead of the original schedule, Armstrong opened the hatch of the lunar module. As he made his way down the lunar module’s ladder, a television camera attached to the craft recorded his progress and beamed the signal back to Earth, where hundreds of millions watched in great anticipation. At 10:56 p.m., Armstrong spoke his famous quote, which he later contended was slightly garbled by his microphone and meant to be “that’s one small step for a man, one giant leap for mankind.” He then planted his left foot on the gray, powdery surface, took a cautious step forward, and humanity had walked on the moon.“Buzz” Aldrin joined him on the moon’s surface at 11:11 p.m., and together they took photographs of the terrain, planted a U.S. flag, ran a few simple scientific tests, and spoke with President Richard M. Nixon via Houston. By 1:11 a.m. on July 21, both astronauts were back in the lunar module and the hatch was closed. The two men slept that night on the surface of the moon, and at 1:54 p.m. the Eagle began its ascent back to the command module. Among the items left on the surface of the moon was a plaque that read: “Here men from the planet Earth first set foot on the moon–July 1969 A.D–We came in peace for all mankind.”At 5:35 p.m., Armstrong, and Aldrin successfully docked and rejoined Collins, and at 12:56 a.m. on July 22 Apollo 11 began its journey home, safely splashing down in the Pacific Ocean at 12:51 p.m. on July 24.There would be five more successful lunar landing missions, and one unplanned lunar swing-by, Apollo 13. The last men to walk on the moon, astronauts Eugene Cernan and Harrison Schmitt of the Apollo 17 mission, left the lunar surface on December 14, 1972. The Apollo program was a costly and labor-intensive endeavor, involving an estimated 400,000 engineers, technicians, and scientists, and costing $24 billion (close to $100 billion in today’s dollars). The expense was justified by Kennedy’s 1961 mandate to beat the Soviets to the moon, and after the feat was accomplished ongoing missions lost their viability. Share on Facebook Tweet on Twitter Support conservation and fish with NEW Florida specialty license plate Save my name, email, and website in this browser for the next time I comment. You have entered an incorrect email address! Please enter your email address here 1 COMMENT Please enter your name here LEAVE A REPLY Cancel replycenter_img Mama Mia Reply July 20th, 1969, man walks on the moon for the first time……how well I remember, as I was right there, uh, not on the moon of course, just hanging out, in 1969. Yes, 1969, man walks on the moon for the first time, yet fast forward to July 23, 2018, and the City of Apopka can’t seem to get the audio posted on the city’s website, Apopka.net, for us citizens to listen in, to the last city council meeting, where they all voted to raise the property millage rate up on us citizens. I called the city to see what the problem was, and they said they would send a note to the IT guy, and give it a few days. I said okay. I see the city hall is back in the picture, and that the budget workshop is now audible, but not the last city council meeting. Have we really progressed in 49 years of history????? LOL Please enter your comment! The Anatomy of Fear TAGSNeil ArmstrongThe HIstory Channel Previous articleCity Council raises millage rate to 4.2876Next articleCookies and Milk with a Cop tomorrow morning Denise Connell RELATED ARTICLESMORE FROM AUTHOR Free webinar for job seekers on best interview answers, hosted by Goodwill June 11 last_img read more

Day two of London’s 100 richest people

first_img Tagged with: Prospect research Recruitment / people Research / statistics The Evening Standard today publishes the second installment of its report on the 100 wealthiest people in London.The three-page report profiles thirty wealthy residents of London or people who have substantial assets in the capital. They range fom Edward Atkin at number 70, worth £172 million due to his baby bottles and feeding equipment company, to property dealer brothers Eddie Zakay and Sol Zakay at number 41 worth around £340 million.The list and profiles are not published online so you will need to pick up a copy of the printed paper this evening on the way home. The Evening Standard is published in London, but is on sale at some newsagents throughout the south east of England. Advertisement About Howard Lake Howard Lake is a digital fundraising entrepreneur. Publisher of UK Fundraising, the world’s first web resource for professional fundraisers, since 1994. Trainer and consultant in digital fundraising. Founder of Fundraising Camp and co-founder of GoodJobs.org.uk. Researching massive growth in giving. Howard Lake | 13 January 2004 | News Day two of London’s 100 richest people  29 total views,  1 views today AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThislast_img read more

Cisco Systems and CTT launch series of web-based ICT seminars

Cisco Systems and CTT launch series of web-based ICT seminars Advertisement Virtual Private Networks (VPN): how to increase communication and collaboration within an organisation, especially those with mobile workers, or remote locations wishing to connect to one another and a central network. The web seminar will take place on 20 April 2005 at 14.00 and on 10 May at 14.00.collaboration and e-learning: learn aboutvoice, Internet and video conferencing to enable distribution of information. This should be useful for organisations that run projects that need input from multiple people, have teams that need to share information and collaborate on work, need to hold frequent meetings, or run training sessions with people in different locations or at home. The web seminar will be held on 29 April 2005 at 14.00 and on 12 May at the same time.Extranet resources: learn about extranet implementation and how it can help yourorganisation e.g by making resources available to remote workers, supporters, contributors, and users over the web. The web seminar will be held on 4 May 2005 at 14.00 and repeated on 16 May at the same time. AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis  19 total views,  1 views today AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis About Howard Lake Howard Lake is a digital fundraising entrepreneur. Publisher of UK Fundraising, the world’s first web resource for professional fundraisers, since 1994. Trainer and consultant in digital fundraising. Founder of Fundraising Camp and co-founder of GoodJobs.org.uk. Researching massive growth in giving. Cisco and Charity Technology Trust (CTT) are partnering to present a series of free information and communications technology (ICT) seminars aimed at helping the charity sector make better use of technology.The first series will comprise three free web-based seminars on the followingtopics: Howard Lake | 30 March 2005 | News read more

Sport Relief application deadline close

first_imgAn application form can be obtained by contacting Cormac McAleer on 02890245927 or [email protected] About Howard Lake Howard Lake is a digital fundraising entrepreneur. Publisher of UK Fundraising, the world’s first web resource for professional fundraisers, since 1994. Trainer and consultant in digital fundraising. Founder of Fundraising Camp and co-founder of GoodJobs.org.uk. Researching massive growth in giving. Howard Lake | 9 July 2007 | News AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis Sport Relief and its Northern Ireland partner, the Community Foundation for Northern Ireland, are accepting applications for the next round of funding, with a deadline of 26th July. Sport Relief was set up by Comic Relief and BBC Sport to support community organisations using sport to make a lasting impact on the lives of disadvantaged people. Sport Relief has two themes — increasing access to sport and exercise for people who face social exclusion and helping people who are experiencing difficulties in their lives to regain their confidence and self-esteem. Groups working with more disadvantaged people will be prioritised over sporting organisations seeking running costs. Grants will be awarded in the range of £1,000 to £10,000. The overall budget for 2007 and 2008 is £60,000 annually. The next deadline after 26th July is 14th November. Advertisementcenter_img  29 total views,  1 views today AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to LinkedInLinkedInShare to EmailEmailShare to WhatsAppWhatsAppShare to MessengerMessengerShare to MoreAddThis Tagged with: Ireland Sport Relief application deadline closelast_img read more

Elevar Therapeutics Announces Orphan Drug Designation for Rivoceranib (Apatinib) for the Treatment of Adenoid…

first_img Facebook WhatsApp Previous articleSchneider Electric Calls for Stronger Collaboration in Industries of the FutureNext articleElematec Corporation To Distribute NevadaNanotech Inc.’s Innovative Molecular Property Spectrometer™ Flammable Gas Sensors In Japan Digital AIM Web Support Twitter Twitter Elevar Therapeutics Announces Orphan Drug Designation for Rivoceranib (Apatinib) for the Treatment of Adenoid Cystic Carcinoma (ACC) Facebook SALT LAKE CITY, Feb. 8, 2021 /PRNewswire/ — Elevar Therapeutics, Inc. (“Elevar”), a fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options, today announced that the U.S. Food and Drug Administration (FDA) has granted rivoceranib (apatinib) with orphan drug designation for the treatment of adenoid cystic carcinoma (ACC), a rare form of cancer that most commonly develops in the salivary glands or other regions of the head and neck. Approximately 1,200 new cases of ACC are diagnosed each year in the United States. The FDA’s Office of Orphan Drug Products grants orphan status to medicines for underserved patient populations, or rare disorders, that affect fewer than 200,000 people in the U.S. “We are pleased by the FDA’s recognition of the critical need to develop treatments for adenoid cystic carcinoma (ACC) given the progressive nature of the disease,” said Alex Kim, chief executive officer of Elevar. “The orphan drug designation provides further momentum for the rivoceranib development program, which we are committed to advancing as quickly as possible for patients in need.” ACC is considered a slow growing but relentless cancer that is characterized by nerve invasion and metastases. Although good local control is usually achieved by resection of the primary tumor and adjuvant radiation therapy, more than half of patients eventually have recurrent and/or metastatic disease. Currently, no curative treatments are available for these patients which underscores the need for effective new therapies. “With no approved treatments for adenoid cystic carcinoma (ACC), a significant unmet need remains for therapies that slow or stop this relentless disease,” said Mark Gelder, M.D., chief medical officer of Elevar. “The orphan drug designation from the FDA reinforces the urgency of Elevar’s work with rivoceranib in ACC and our commitment to improving treatment experiences and outcomes for patients who have limited or inadequate therapeutic options.” In November 2020, Elevar announced that the Company met its initial 55 patient enrollment target for its Phase 2, open-label, multicenter, clinical trial of rivoceranib in patients with recurrent or metastatic ACC one year ahead of schedule. The Company also announced increasing the target size of the trial to approximately 72 patients to further explore the potential clinical benefit of rivoceranib in this patient population. About Rivoceranib (apatinib) Rivoceranib is the first small-molecule tyrosine kinase inhibitor (TKI) to be approved in gastric cancer (China, Dec 2014). It has been granted Orphan Drug designation in the U.S., Europe and South Korea and has been clinically tested in over 1,000 patients worldwide. Rivoceranib acts by inhibiting angiogenesis, a critical process in cancer growth and proliferation. Specifically, rivoceranib potently and selectively inhibits VEGFR-2 which mediates the primary pathway for tumor-mediated angiogenesis. As a best-in-class therapeutic known for its safety and tolerability, Elevar believes rivoceranib has the potential to significantly improve clinical outcomes in combination with chemotherapeutics and immunotherapy, as well as for maintenance therapy. Elevar Therapeutics is developing rivoceranib for the treatment of patients with gastric cancer, colorectal cancer, hepatocellular carcinoma, and adenoid cystic carcinoma. About Elevar Therapeutics Elevar Therapeutics (formerly LSK BioPharma) is a rapidly growing, fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options. Elevar’s lead proprietary drug candidates include rivoceranib (apatinib) and Apealea® (paclitaxel micellar). Rivoceranib is the first small-molecule tyrosine kinase inhibitor (TKI) to be approved in gastric cancer (China, Dec 2014). It has been granted Orphan Drug designation in the U.S., Europe and South Korea and has been clinically tested in over 1,000 patients worldwide in numerous cancer indications. Apealea is a non-Cremophor EL based formulation of paclitaxel that received marketing authorization by the European Commission in November 2018, making it Europe’s first non-Cremophor EL formulation of paclitaxel approved for use in ovarian cancer. Elevar Therapeutics has offices in Utah, California and South Korea, and additional information is available at www.elevartherapeutics.com. Elevar Media Contact: Elixir Health Public Relations Lindsay Rocco (862) 596-1304 [email protected] View original content to download multimedia: http://www.prnewswire.com/news-releases/elevar-therapeutics-announces-orphan-drug-designation-for-rivoceranib-apatinib-for-the-treatment-of-adenoid-cystic-carcinoma-acc-301223366.html SOURCE Elevar Therapeuticscenter_img TAGS  By Digital AIM Web Support – February 8, 2021 WhatsApp Local NewsBusiness Pinterest Pinterestlast_img read more

Slowey’s political future could be determined today

first_img HSE warns of ‘widespread cancellations’ of appointments next week Facebook By News Highland – April 26, 2011 Dail to vote later on extending emergency Covid powers Twitter Newsx Adverts Google+ Facebook The political future of Fine Gael Councillor Terence Slowey may become clearer today when Donegal County Council considers a report into his double expenses claim in October 2008.A recent report by the Standards in Public Office commission found he had breached guidelines and acted recklessly.During the same weekend in October 2008, Cllr Slowey attended a local authority conference in Cork and a cross border conference in Kerry. However, he submitted two seperate travel expenses claims, and was overpaid by almost a thousand euro.When what happened came to light, he immediately repaid the money, acknowledged his mistake and apologised.However, after he appeared at a Standards in Public Office commission hearing last month, Cllr Slowey’s actions were described as “reckless” in the subsequent  report. He was deemed to have breached ethical guidelines, and the case was described as a serious matter.The council, and the Ministers for Environment and Finance were formally informed of the judgement, with the Department of the Environment saying it’s a matter for the council to decide what action, if any, to take.The council’s April meeting takes place today, with consideration of the commission’s report the second item on the agenda. Twitter WhatsApp Google+center_img Slowey’s political future could be determined today RELATED ARTICLESMORE FROM AUTHOR Pinterest PSNI and Gardai urged to investigate Adams’ claims he sheltered on-the-run suspect in Donegal Previous articleThree Donegal candidates await lengthy Seanad countNext articleGardai investigate armed robbery at Bundoran KFC News Highland Man arrested on suspicion of drugs and criminal property offences in Derry Pinterest WhatsApp Man arrested in Derry on suspicion of drugs and criminal property offences released Dail hears questions over design, funding and operation of Mica redress scheme last_img read more